Avgo Biotech is EIS – SEIS compliant and approved.
We are currently looking for £150,000 to enable us to consolidate our commercial and technical position (capital is at risk – investments can go down as well as go up).
Customer commitment will enable us to invest in commercial facilities and plant – with a target market entry of Q3 2022.
If you are interested in supporting AVGO, please contact:
Mob: 07802 888742